DATA SCIENCE, CANCER AND SEQUENCING ANALYSES

Recent developments in technology led to exponential growth in processing speed, storage capacities and communication rates. These available resources allowed the creation of thousands of applications that run on smart devices and the world wide web. Today we generate lots of data using these applications and the availability of vast digital data created a new field: data science. Data science aims to utilize digital data to develop solutions to improve human life. Next-generation sequencing technologies enabled the generation of high-throughput genomic data from DNA and RNA. Considering the great potential for genomic data to understand biological functions and the substantial drop in sequencing costs; the amount of available data increased exponentially over time. Sequencing technologies are based on the shredding of the DNA and capture of short reads. These reads are then combined to identify the genomic map of the biological sample. Some of our studies are based on extraction of multiple samples from a tumor and application of sequencing on these samples to understand the tumor development, progression and drug response. Unfortunately, all the frequently used analysis algorithms are based on optimistic assumptions. High level of disparity is observed in literature and in our studies when we compare different algorithms. Currently, we do extensive testing on realistic scenarios to understand the sources of variation in the results. Finally, we develop a user-friendly analysis platform for comparative sequencing analyses to enhance the cooperation among scientists with different backgrounds on sequencing projects.

DATA SCIENCE, CANCER AND SEQUENCING ANALYSES

Recent developments in technology led to exponential growth in processing speed, storage capacities and communication rates. These available resources allowed the creation of thousands of applications that run on smart devices and the world wide web. Today we generate lots of data using these applications and the availability of vast digital data created a new field: data science. Data science aims to utilize digital data to develop solutions to improve human life. Next-generation sequencing technologies enabled the generation of high-throughput genomic data from DNA and RNA. Considering the great potential for genomic data to understand biological functions and the substantial drop in sequencing costs; the amount of available data increased exponentially over time. Sequencing technologies are based on the shredding of the DNA and capture of short reads. These reads are then combined to identify the genomic map of the biological sample. Some of our studies are based on extraction of multiple samples from a tumor and application of sequencing on these samples to understand the tumor development, progression and drug response. Unfortunately, all the frequently used analysis algorithms are based on optimistic assumptions. High level of disparity is observed in literature and in our studies when we compare different algorithms. Currently, we do extensive testing on realistic scenarios to understand the sources of variation in the results. Finally, we develop a user-friendly analysis platform for comparative sequencing analyses to enhance the cooperation among scientists with different backgrounds on sequencing projects.

___

  • Wellek S, Blettner M. On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2012;109(15):276-81
Sağlık Bilimlerinde İleri Araştırmalar Dergisi-Cover
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 2018
  • Yayıncı: İstanbul Üniversitesi
Sayıdaki Diğer Makaleler

TUMOR-ASSOCIATED MICROBIOME

Ayşe CANER

LONG NON-CODING RNAs AND AUTOPHAGY IN OSTEOSARCOMA

Ayça COŞKUN, Hamza Malik OKUYAN

EXOSOMES – A NEW FRONTIER IN CANCER THERAPY

Sevgi GEZİCİ

NOVEL EPIGENETIC BIOMARKER DETERMINATION FOR OSCC BY ARRAY-BASED EPIGENOMIC AND TRANSCRIPTOMIC TECHNIQUES

Semra DEMOKAN, Sena SEN, Onder ERYILMAZ, Sevde COMERT, Murat ULUSAN, Mehmet Nejat DALAY

APPLICATIONS OF TRANSCRIPTOMICS METHODS IN BREAST CANCER

Yesim GOKMEN-POLAR

EVALUATION OF EXOSOME-DERIVED CircRNA EXPRESSION PATTERNS IN LUNG CANCER RADIOTHERAPY

Saina RAHİMİ, Milad ASADİ, Can MUFTUOGLU, Emin TAVLAYAN, Ozlem OZKAYA AKAGUNDUZ, Ufuk MERT, Ayse CANER

CircRNAs OF SALIVA AS POTENTIAL BIOMARKERS FOR COLORECTAL CANCER DIAGNOSIS

Afet SATTAROVA, Milad ASADİ, Tayfun YOLDAŞ, Osman BOZBIYIK, Ahmad AL-OMAR, Can MUFTUOGLU, Ufuk MERT, Ayşe CANER

miRNA-REGULATED PATHWAYS OF CD8+T CELLS IN TNBC MOUSE MODEL

Muge OCAL-DEMİRTAS, Doç. Dr. Bala GÜR DEDEOĞLU

NETWORK AND PATHWAY BASED ANALYSIS OF MULTI-OMIC DATA TO ENLIGHTEN MOLECULAR MECHANISMS OF COMPLEX DISEASES

Burcu GÜNGÖR

THERAPEUTIC IMPLICATIONS OF TARGETED SEQUENCING AND miRNA-SEQ OF B CELL LYMPHOMAS

Esra Esmeray SÖNMEZ, Tevfik HATİPOĞLU, Xiaozhou HU, Hongling YUAN, Ayça ERŞEN DANYELİ, Ayla ANAR ARICI, Ahmet ŞEYHANLI, Zühal ÖNDER SİVİŞ, Bengü DEMİRAĞ, Eda ATASEVEN, Dilek İNCE, Zekiye ALTUN, Safiye AKTAŞ, İnci ALACACIOĞLU, Tuğba SÜZEK, Nazan ÖZSAN, Taner Kemal ERDAĞ, Elvan Caglar CİTAK, Sermin ÖZ